Aimaretti Gianluca, Baffoni Claudia, Broglio Fabio, Janssen Joop A M, Corneli Ginevra, Deghenghi Romano, van der Lely Aart Jan, Ghigo Ezio, Arvat Emanuela
Department of Internal Medicine, University of Turin, Italy.
Clin Endocrinol (Oxf). 2002 Jun;56(6):765-71. doi: 10.1046/j.1365-2265.2002.01547.x.
Ghrelin, a 28 amino acid acylated peptide, is a natural ligand of the GH secretagogues (GHS) receptor (GHS-R), which is specific for synthetic GHS. Similar to synthetic GHS, ghrelin strongly stimulates GH secretion but also displays significant stimulatory effects on lactotroph and corticotroph secretion. It has been hypothesized that isolated GH deficiency (GHD) could reflect hypothalamic impairment that would theoretically involve defect in ghrelin activity.
In the present study, we verified the effects of ghrelin (1 microg/kg i.v.) on GH, PRL, ACTH and cortisol levels in adult patients with isolated severe GHD [five males and one female, age (mean +/- SEM) 24.7 +/- 2.6 years, BMI 25.7 +/- 2.7 kg/m2]. In all patients, the GH response to insulin-induced hypoglycaemia (ITT, 0.1 IU regular insulin i.v.) and GH releasing hormone (GHRH) (1 microg/kg i.v.) + arginine (ARG, 0.5 g/kg i.v.) was also studied. The hormonal responses in GHD were compared with those in age-matched normal subjects (NS, seven males, age 28.6 +/- 2.9 years, BMI 22.1 +/- 0.8 kg/m2).
IGF-I levels in GHD were markedly lower than in NS (69.8 +/- 11.3 vs. 167.9 +/- 19.2 microg/l, P < 0.003). Ghrelin administration induced significant increase in GH, PRL, ACTH and cortisol levels in all GHD. In GHD, the GH response to ghrelin was higher (P < 0.05) than that to GHRH + ARG, which, in turn, was higher (P < 0.05) than that to ITT (9.2 +/- 4.1 vs. 5.3 +/- 1.7 vs. 1.4 +/- 0.4 microg/l). These GH (1 microg/l = 2 mU/l) responses in GHD were markedly lower (P < 0.0001) than those in NS (ghrelin vs. GHRH + ARG vs. ITT 92.1 +/- 16.7 vs. 65.3 +/- 8.9 vs. 17.7 +/- 3.5 microg/l). In GHD, the highest individual peak GH response to ghrelin was markedly lower than the lowest peak GH response in NS (28.5 vs. 42.9 microg/l). GHD and NS showed overlapping PRL (1 microg/l = 32 mU/l) (10.0 +/- 1.4 vs. 14.9 +/- 2.2 microg/l), ACTH (22.3 +/- 5.3 vs. 18.7 +/- 4.6 pmol/l) and cortisol responses (598.1 +/- 52.4 vs. 486.9 +/- 38.9 nmol/l).
This study shows that ghrelin is one of the most powerful provocative stimuli of GH secretion, even in those patients with isolated severe GHD. In this condition, however, the somatotroph response is markedly reduced while the lactotroph and corticotroph responsiveness to ghrelin is fully preserved, indicating that this endocrine activity is fully independent of mechanisms underlying the GH-releasing effect. These results do not support the hypothesis that ghrelin deficiency is a major cause of isolated GH deficiency but suggest that ghrelin might represent a reliable provocative test to evaluate the maximal GH secretory capacity provided that appropriate cut-off limits are assumed.
胃饥饿素是一种含28个氨基酸的酰化肽,是生长激素促分泌素(GHS)受体(GHS-R)的天然配体,该受体对合成GHS具有特异性。与合成GHS相似,胃饥饿素能强烈刺激生长激素分泌,但对催乳素细胞和促肾上腺皮质激素细胞的分泌也有显著刺激作用。据推测,孤立性生长激素缺乏症(GHD)可能反映了下丘脑功能障碍,理论上这会涉及胃饥饿素活性缺陷。
在本研究中,我们验证了胃饥饿素(1微克/千克静脉注射)对成年孤立性严重GHD患者[5名男性和1名女性,年龄(平均值±标准误)24.7±2.6岁,体重指数25.7±2.7千克/平方米]生长激素、催乳素、促肾上腺皮质激素和皮质醇水平的影响。在所有患者中,还研究了生长激素对胰岛素诱导的低血糖(ITT,静脉注射0.1单位正规胰岛素)和生长激素释放激素(GHRH)(1微克/千克静脉注射)+精氨酸(ARG,0.5克/千克静脉注射)的反应。将GHD患者的激素反应与年龄匹配的正常受试者(NS,7名男性,年龄28.6±2.9岁,体重指数22.1±0.8千克/平方米)的反应进行比较。
GHD患者的胰岛素样生长因子-I水平明显低于NS组(69.8±11.3对167.9±19.2微克/升,P<0.003)。给予胃饥饿素后,所有GHD患者的生长激素、催乳素、促肾上腺皮质激素和皮质醇水平均显著升高。在GHD患者中,生长激素对胃饥饿素的反应高于(P<0.05)对GHRH+ARG的反应,而后者又高于(P<0.05)对ITT的反应(9.2±4.1对5.3±1.7对1.4±0.4微克/升)。GHD患者的这些生长激素(每1微克/升=2毫单位/升)反应明显低于(P<0.0001)NS组(胃饥饿素对GHRH+ARG对ITT为92.1±16.7对65.3±8.9对17.7±3.5微克/升)。在GHD患者中,胃饥饿素引起的最高个体生长激素峰值反应明显低于NS组的最低生长激素峰值反应(28.5对42.9微克/升)。GHD患者和NS组的催乳素(每1微克/升=32毫单位/升)(10.0±1.4对14.9±2.2微克/升)、促肾上腺皮质激素(22.3±5.3对18.7±4.6皮摩尔/升)和皮质醇反应(598.1±52.4对486.9±38.9纳摩尔/升)有重叠。
本研究表明,即使在孤立性严重GHD患者中,胃饥饿素也是生长激素分泌最有力的激发刺激之一。然而,在这种情况下,生长激素细胞的反应明显降低,而催乳素细胞和促肾上腺皮质激素细胞对胃饥饿素的反应性完全保留,这表明这种内分泌活性完全独立于生长激素释放作用的潜在机制。这些结果不支持胃饥饿素缺乏是孤立性生长激素缺乏的主要原因这一假设,但表明如果设定适当的临界值,胃饥饿素可能是评估最大生长激素分泌能力的可靠激发试验。